Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q1)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5.59%3.89B | 0.28%7.4B | 4.82%3.68B | -5.30%7.38B | -3.67%3.51B | -9.09%7.8B | -14.74%3.65B | 7.38%8.58B | 10.80%4.28B | 12.94%2.18B |
| Operating income | 5.59%3.89B | 0.28%7.4B | 4.82%3.68B | -5.30%7.38B | -3.67%3.51B | -9.09%7.8B | -14.74%3.65B | 7.38%8.58B | 10.80%4.28B | 12.94%2.18B |
| Cost of sales | -8.43%-2.26B | 5.19%-4.29B | -2.20%-2.08B | -2.88%-4.53B | -6.64%-2.04B | 0.43%-4.4B | 10.43%-1.91B | -10.44%-4.42B | -16.18%-2.13B | -19.69%-1.07B |
| Operating expenses | -8.43%-2.26B | 5.19%-4.29B | -2.20%-2.08B | -2.88%-4.53B | -6.64%-2.04B | 0.43%-4.4B | 10.43%-1.91B | -10.44%-4.42B | -16.18%-2.13B | -19.69%-1.07B |
| Gross profit | 1.88%1.63B | 8.95%3.11B | 8.43%1.6B | -15.92%2.85B | -15.03%1.47B | -18.31%3.39B | -19.04%1.73B | 4.30%4.15B | 5.91%2.14B | 7.15%1.12B |
| Selling expenses | 7.82%-1.01B | -8.87%-2.08B | -14.07%-1.1B | 11.96%-1.91B | 15.65%-963.53M | 10.17%-2.17B | -2.23%-1.14B | -16.72%-2.41B | -13.41%-1.12B | -12.44%-557.11M |
| Administrative expenses | -15.05%-299.65M | -2.73%-550.05M | 5.53%-260.45M | 11.39%-535.41M | 6.50%-275.7M | -16.17%-604.22M | 11.98%-294.86M | 24.95%-520.1M | -4.21%-334.99M | -11.91%-174.01M |
| Research and development expenses | 3.00%-51.18M | 4.98%-125.45M | 6.07%-52.77M | 33.02%-132.03M | 35.06%-56.18M | -2.04%-197.1M | ---86.51M | ---193.16M | ---- | ---- |
| Impairment and provision | -3,718.06%-5.5M | -204.44%-26.01M | -107.70%-144K | 47.05%-8.54M | 140.81%1.87M | 68.13%-16.13M | ---4.59M | ---50.63M | ---- | ---- |
| -Other impairment is provision | -3,718.06%-5.5M | -204.44%-26.01M | -107.70%-144K | 47.05%-8.54M | 140.81%1.87M | 68.13%-16.13M | ---4.59M | ---50.63M | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 19.89%-11.63M | 13.30%-6.02M |
| Special items of operating profit | -118.85%-4.05M | 301.82%52.56M | -64.87%21.51M | 109.80%13.08M | 156.72%61.22M | -456.39%-133.52M | -5.50%23.85M | -1,816.52%-24M | 115.12%25.23M | 131.20%11.91M |
| Operating profit | 22.95%254.2M | 35.51%381.71M | -14.25%206.76M | 2.55%281.68M | 5.02%241.13M | -71.18%274.67M | -67.34%229.6M | -20.23%953.1M | 31.59%703.08M | 13.14%390.57M |
| Financing cost | 46.06%-16.78M | 10.54%-51.64M | -60.12%-31.11M | -286.31%-57.73M | -73.03%-19.43M | 20.32%-14.94M | ---11.23M | ---18.75M | ---- | ---- |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -95.91%619K | -137.43%-1.57M |
| Special items of earning before tax | 181.60%3.74M | 20.75%-17.55M | -149.57%-4.58M | -162.06%-22.15M | 77.85%9.23M | 80.66%-8.45M | --5.19M | ---43.69M | ---- | ---- |
| Earning before tax | 40.96%241.16M | 54.86%312.52M | -25.92%171.08M | -19.69%201.8M | 3.30%230.93M | -71.79%251.28M | -68.23%223.56M | -27.05%890.65M | 28.07%703.7M | 11.34%389M |
| Tax | -176.49%-60.31M | -98.28%-65.32M | 60.20%-21.81M | 47.65%-32.95M | -69.49%-54.81M | 61.84%-62.93M | 74.53%-32.34M | 25.30%-164.94M | 2.09%-126.98M | 14.29%-67.5M |
| After-tax profit from continuing operations | 21.16%180.86M | 46.39%247.19M | -15.25%149.27M | -10.35%168.86M | -7.90%176.13M | -74.05%188.34M | -66.84%191.23M | -27.43%725.71M | 37.39%576.72M | 18.79%321.49M |
| Earning after tax | 21.16%180.86M | 46.39%247.19M | -15.25%149.27M | -10.35%168.86M | -7.90%176.13M | -74.05%188.34M | -66.84%191.23M | -27.43%725.71M | 37.39%576.72M | 18.79%321.49M |
| Minority profit | -89.63%402K | 302.82%11.22M | 145.75%3.88M | 80.37%-5.53M | 41.49%-8.47M | 25.99%-28.18M | 34.75%-14.48M | -835.17%-38.08M | -301.58%-22.2M | -1,030.71%-9.94M |
| Profit attributable to shareholders | 24.12%180.45M | 35.32%235.98M | -21.24%145.39M | -19.46%174.39M | -10.26%184.6M | -71.65%216.53M | -65.65%205.71M | -23.93%763.79M | 46.52%598.92M | 22.95%331.43M |
| Basic earnings per share | 24.11%0.1014 | 36.70%0.1326 | -20.29%0.0817 | -19.70%0.097 | -10.56%0.1025 | -72.84%0.1208 | -67.15%0.1146 | -27.01%0.4447 | 37.52%0.3489 | |
| Diluted earnings per share | 24.11%0.1014 | 36.70%0.1326 | -20.29%0.0817 | -19.70%0.097 | -10.56%0.1025 | -72.75%0.1208 | -67.06%0.1146 | -26.81%0.4433 | 39.33%0.3479 | |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | Ernst & Young Accounting Firm | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.